High Tech Pharm Co. Ltd (106190) — Cash Flow Quality Index

Latest as of September 2025: 1.74x

High Tech Pharm Co. Ltd (106190) has a Cash Flow Quality Index of 1.74x as of September 2025. Operating cash flow of ₩6.60 Billion exceeds net income of ₩3.79 Billion, indicating high earnings quality where cash backs reported profits. Explore High Tech Pharm Co. Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.74x
Operating CF / Net Income

Operating Cash Flow

₩6.60 Billion
KRW

Net Income

₩3.79 Billion
KRW

Data as of

Sep 2025
Most recent filing

High Tech Pharm Co. Ltd Cash Flow Quality Index (2014–2024)

Historical Cash Flow Quality Index for High Tech Pharm Co. Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check High Tech Pharm Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for High Tech Pharm Co. Ltd (2014–2024)

Year-by-year earnings quality comparison for High Tech Pharm Co. Ltd. For live market cap and the full company financial profile, see 106190 market cap overview.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2024 0.86x ₩14.69 Billion ₩17.09 Billion ▲ +191.6%
2023 0.29x ₩2.91 Billion ₩9.86 Billion ▲ +146.8%
2022 -0.63x ₩-3.70 Billion ₩5.87 Billion ▼ -130.6%
2018 2.06x ₩5.38 Billion ₩2.61 Billion ▼ -20.6%
2017 2.60x ₩5.45 Billion ₩2.10 Billion ▲ +847.0%
2016 0.27x ₩1.45 Billion ₩5.28 Billion ▼ -85.9%
2015 1.94x ₩12.71 Billion ₩6.54 Billion ▲ +49.6%
2014 1.30x ₩10.17 Billion ₩7.84 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.